Status:

COMPLETED

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Cocaine Use Disorder

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

This is an 8-week, double-blind, randomized placebo-controlled trial of the efficacy of a combination of extended-release naltrexone (XR-NTX) and extended-release buprenorphine (XR-BUP) compared to ma...

Detailed Description

The primary objective of this study is to assess the efficacy of XR-NTX plus XR-BUP as a combination pharmacotherapy for CUD. Approximately four hundred and twenty-six adults will be randomized into t...

Eligibility Criteria

Inclusion

  • Individuals must meet all of the inclusion criteria and no exclusion criteria in order to be eligible to participate in the study, including but not limited to:
  • Be 18 to 65 years of age;
  • Be interested in reducing or stopping cocaine use.
  • Be willing to comply with all study procedures and medication instructions.

Exclusion

  • 1\. Have any condition for which, in the opinion of the site investigator or designee, study participation would not be in their best interest or that could prevent, limit, or confound the protocol-specified assessments.

Key Trial Info

Start Date :

April 18 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 21 2025

Estimated Enrollment :

427 Patients enrolled

Trial Details

Trial ID

NCT05262270

Start Date

April 18 2023

End Date

July 21 2025

Last Update

October 21 2025

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35209

2

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States, 72205

3

UCLA Vine Street Clinic

Los Angeles, California, United States, 90038

4

Center on Substance Use and Health (CSUH)

San Francisco, California, United States, 94102